Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 277.86K |
Day Range | - - - |
52 Wk Range | 12.54 - 27.24 |
Market Cap | $1.68B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 6.48% |
Days to Cover | 13.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Nurix Therapeutics (NASDAQ:NRIX).
There is no analysis for Bicycle Therapeutics.
Bicycle Therapeutics has a consensus price target of $46.92.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $23.57 last updated July 24, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.